Structural Model for Phenylalkylamine Binding to L-type Calcium Channels

Overview

Journal J Biol Chem

Specialty Biochemistry

Date 2009 Aug 25

PMID 19700404

Citations 22

Authors

Ricky C K Cheng

Denis B Tikhonov

Boris S Zhorov

Affiliations

Soon will be listed here.

Abstract

Phenylalkylamines (PAAs), a major class of L-type calcium channel (LTCC) blockers, have two aromatic rings connected by a flexible chain with a nitrile substituent. Structural aspects of ligand-channel interactions remain unclear. We have built a KvAP-based model of LTCC and used Monte Carlo energy minimizations to dock devapamil, verapamil, gallopamil, and other PAAs. The PAA-LTCC models have the following common features: (i) the meta-methoxy group in ring A, which is proximal to the nitrile group, accepts an H-bond from a PAA-sensing Tyr_IIIS6; (ii) the meta-methoxy group in ring B accepts an H-bond from a PAA-sensing Tyr_IVS6; (iii) the ammonium group is stabilized at the focus of P-helices; and (iv) the nitrile group binds to a Ca(2+) ion coordinated by the selectivity filter glutamates in repeats III and IV. The latter feature can explain Ca(2+) potentiation of PAA action and the presence of an electronegative atom at a similar position of potent PAA analogs. Tyr substitution of a Thr in IIIS5 is known to enhance action of devapamil and verapamil. Our models predict that the para-methoxy group in ring A of devapamil and verapamil accepts an H-bond from this engineered Tyr. The model explains structure-activity relationships of PAAs, effects of LTCC mutations on PAA potency, data on PAA access to LTCC, and Ca(2+) potentiation of PAA action. Common and class-specific aspects of action of PAAs, dihydropyridines, and benzothiazepines are discussed in view of the repeat interface concept.

Citing Articles

Modulation of L-type calcium channels in Alzheimer's disease: A potential therapeutic target.

Crossley C, Rajani V, Yuan Q Comput Struct Biotechnol J. 2022; 21:11-20.

PMID: 36514335 PMC: 9719069. DOI: 10.1016/j.csbj.2022.11.049.

P-Loop Channels: Experimental Structures, and Physics-Based and Neural Networks-Based Models.

Tikhonov D, Zhorov B Membranes (Basel). 2022; 12(2).

PMID: 35207150 PMC: 8876033. DOI: 10.3390/membranes12020229.

Nitrile-containing pharmaceuticals: target, mechanism of action, and their SAR studies.

Wang X, Wang Y, Li X, Yu Z, Song C, Du Y RSC Med Chem. 2021; 12(10):1650-1671.

PMID: 34778767 PMC: 8528211. DOI: 10.1039/d1md00131k.

Seeking the exclusive binding region of phenylalkylamine derivatives on human T-type calcium channels via homology modeling and molecular dynamics simulation approach.

Lu Y, Li M, Lee G, Zhao N, Chen Z, Edwards A Pharmacol Res Perspect. 2021; 9(3):e00783.

PMID: 33984189 PMC: 8118199. DOI: 10.1002/prp2.783.

A New Computer Model for Evaluating the Selective Binding Affinity of Phenylalkylamines to T-Type Ca Channels.

Lu Y, Li M Pharmaceuticals (Basel). 2021; 14(2).

PMID: 33578931 PMC: 7916697. DOI: 10.3390/ph14020141.

References

Nawrath H, Wegener J . Kinetics and state-dependent effects of verapamil on cardiac L-type calcium channels. Naunyn Schmiedebergs Arch Pharmacol. 1997; 355(1):79-86. DOI: 10.1007/pl00004921. View

Lacinova L . Voltage-dependent calcium channels. Gen Physiol Biophys. 2005; 24 Suppl 1:1-78. View

Seydl K, KIMBALL D, Schindler H, Romanin C . The benzazepine/benzothiazepine binding domain of the cardiac L-type Ca2+ channel is accessible only from the extracellular side. Pflugers Arch. 1993; 424(5-6):552-4. DOI: 10.1007/BF00374922. View

Gouaux E, MacKinnon R . Principles of selective ion transport in channels and pumps. Science. 2005; 310(5753):1461-5. DOI: 10.1126/science.1113666. View

Mannhold R, Holtje H, Koke V . Importance of nitrile substitution for the Ca antagonistic action. Arch Pharm (Weinheim). 1986; 319(11):990-8. DOI: 10.1002/ardp.19863191107. View

Jiang Y, Lee A, Chen J, Ruta V, Cadene M, Chait B . X-ray structure of a voltage-dependent K+ channel. Nature. 2003; 423(6935):33-41. DOI: 10.1038/nature01580. View

Faraldo-Gomez J, Kutluay E, Jogini V, Zhao Y, Heginbotham L, Roux B . Mechanism of intracellular block of the KcsA K+ channel by tetrabutylammonium: insights from X-ray crystallography, electrophysiology and replica-exchange molecular dynamics simulations. J Mol Biol. 2006; 365(3):649-62. DOI: 10.1016/j.jmb.2006.09.069. View

Satoh K, Yanagisawa T, Taira N . Coronary vasodilator and cardiac effects of optical isomers of verapamil in the dog. J Cardiovasc Pharmacol. 1980; 2(3):309-18. DOI: 10.1097/00005344-198005000-00008. View

Bayer R, Kaufmann R, Mannhold R . Inotropic and electrophysiological actions of verapamil and D 600 in mammalian myocardium. II. Pattern of inotropic effects of the optical isomers. Naunyn Schmiedebergs Arch Pharmacol. 1975; 290(1):69-80. DOI: 10.1007/BF00499990. View

10.

Dudley Jr S, Chang N, Hall J, Lipkind G, Fozzard H, French R . mu-conotoxin GIIIA interactions with the voltage-gated Na(+) channel predict a clockwise arrangement of the domains. J Gen Physiol. 2000; 116(5):679-90. PMC: 2229485. DOI: 10.1085/jgp.116.5.679. View

11.

Lipkind G, Fozzard H . Modeling of the outer vestibule and selectivity filter of the L-type Ca2+ channel. Biochemistry. 2001; 40(23):6786-94. DOI: 10.1021/bi010269a. View

12.

Huber I, Wappl-Kornherr E, Sinnegger-Brauns M, Hoda J, Walter-Bastl D, Striessnig J . Opposite effects of a single IIIS5 mutation on phenylalkylamine and dihydropyridine interaction with L-type Ca2+ channels. J Biol Chem. 2004; 279(53):55211-7. DOI: 10.1074/jbc.M409008200. View

13.

Doyle D, Morais Cabral J, Pfuetzner R, Kuo A, Gulbis J, Cohen S . The structure of the potassium channel: molecular basis of K+ conduction and selectivity. Science. 1998; 280(5360):69-77. DOI: 10.1126/science.280.5360.69. View

14.

Bruhova I, Tikhonov D, Zhorov B . Access and binding of local anesthetics in the closed sodium channel. Mol Pharmacol. 2008; 74(4):1033-45. DOI: 10.1124/mol.108.049759. View

15.

Glossmann H, Striessnig J . Molecular properties of calcium channels. Rev Physiol Biochem Pharmacol. 1990; 114:1-105. DOI: 10.1007/BFb0031018. View

16.

Pagel P, Hettrick D, Lowe D, Gowrie P, Kersten J, Bosnjak Z . Cardiovascular effects of verapamil enantiomer combinations in conscious dogs. Eur J Pharmacol. 1998; 348(2-3):213-21. DOI: 10.1016/s0014-2999(98)00145-9. View

17.

Tikhonov D, Zhorov B . Structural model for dihydropyridine binding to L-type calcium channels. J Biol Chem. 2009; 284(28):19006-17. PMC: 2707233. DOI: 10.1074/jbc.M109.011296. View

18.

Hockerman G, Johnson B, Scheuer T, Catterall W . Molecular determinants of high affinity phenylalkylamine block of L-type calcium channels. J Biol Chem. 1995; 270(38):22119-22. DOI: 10.1074/jbc.270.38.22119. View

19.

Striessnig J, Murphy B, Catterall W . Dihydropyridine receptor of L-type Ca2+ channels: identification of binding domains for [3H](+)-PN200-110 and [3H]azidopine within the alpha 1 subunit. Proc Natl Acad Sci U S A. 1991; 88(23):10769-73. PMC: 53012. DOI: 10.1073/pnas.88.23.10769. View

20.

Jiang Y, Lee A, Chen J, Cadene M, Chait B, MacKinnon R . Crystal structure and mechanism of a calcium-gated potassium channel. Nature. 2002; 417(6888):515-22. DOI: 10.1038/417515a. View